熱門資訊> 正文
Bio-Path GAAP每股收益为-1.16美元
2024-08-15 19:04
- Bio-Path press release (NASDAQ:BPTH): Q2 GAAP EPS of -$1.16.
- As of June 30, 2024, the Company had cash of $4.0 million, compared to $1.1 million as of December 31, 2023.
More on Bio-Path
- Bio-Path announces $4.0 million private placement
- Seeking Alpha’s Quant Rating on Bio-Path
- Historical earnings data for Bio-Path
- Financial information for Bio-Path
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
